KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Financing Activities: 2017-2025

Historic Cash from Financing Activities for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $4.3 million.

  • Guardant Health's Cash from Financing Activities rose 250.12% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.8 million, marking a year-over-year decrease of 169.00%. This contributed to the annual value of -$996,000 for FY2024, which is 100.21% down from last year.
  • Per Guardant Health's latest filing, its Cash from Financing Activities stood at $4.3 million for Q3 2025, which was up 166.69% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash from Financing Activities registered a high of $383.9 million during Q2 2023, and its lowest value of -$172.1 million during Q2 2022.
  • Over the past 3 years, Guardant Health's median Cash from Financing Activities value was $1.6 million (recorded in 2025), while the average stood at $37.8 million.
  • Examining YoY changes over the last 5 years, Guardant Health's Cash from Financing Activities showed a top increase of 3,807.16% in 2023 and a maximum decrease of 7,016.67% in 2023.
  • Quarterly analysis of 5 years shows Guardant Health's Cash from Financing Activities stood at $3.8 million in 2021, then crashed by 38.68% to $2.3 million in 2022, then surged by 3,807.16% to $90.6 million in 2023, then plummeted by 103.24% to -$2.9 million in 2024, then spiked by 250.12% to $4.3 million in 2025.
  • Its Cash from Financing Activities stands at $4.3 million for Q3 2025, versus $1.6 million for Q2 2025 and -$66.8 million for Q1 2025.